.Bicara Therapeutics as well as Zenas Biopharma have offered fresh incentive to the IPO market with ...
.Genentech is going to close its own cancer immunology research division, as well as unit head as we...
.Kezar Lifestyle Sciences is falling its dim stage 1 solid growth medicine as the biotech goes all-i...
.Despite izokibep maintaining its own newly found winning streak in the clinic, Acelyrin is no more ...
.Rivus Pharmaceuticals has plumped up the prospects of its own fat-busting, muscle-sparing drug cand...
.Ovid Therapy actually showed last month that it was actually trimming its own head count as the bus...
.Eli Lilly has actually opened up a $700 million R&D center in the Boston Seaport, increasing its...
.Simply five months after securing a $100 million IPO, Boundless Biography is already giving up some...
.The initial phases of oncology R&D may not be short of intriguing brand new methods, and Halda R...
.Psychopharmacology has pulled three write-ups concerning midstage scientific trial information dete...